These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 15990246

  • 41. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M.
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [Abstract] [Full Text] [Related]

  • 42. Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.
    van Kempen-Harteveld ML, Brand R, Kal HB, Verdonck LF, Hofman P, Schattenberg AV, van der Maazen RW, Cornelissen JJ, Eijkenboom WM, van der Lelie JP, Oldenburger F, Barge RM, van Biezen A, Vossen JM, Noordijk EM, Struikmans H.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1444-54. PubMed ID: 18294781
    [Abstract] [Full Text] [Related]

  • 43. Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimens.
    Al-Hazzouri A, Cao Q, Burns LJ, Weisdorf DJ, Majhail NS.
    Bone Marrow Transplant; 2009 Jun 01; 43(12):949-51. PubMed ID: 19104492
    [Abstract] [Full Text] [Related]

  • 44. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G.
    Bone Marrow Transplant; 2007 Jun 01; 39(11):667-75. PubMed ID: 17401396
    [Abstract] [Full Text] [Related]

  • 45. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L, Styczynski J, Komarnicki M.
    Infection; 2007 Dec 01; 35(6):421-7. PubMed ID: 17926001
    [Abstract] [Full Text] [Related]

  • 46. Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group.
    Faraci M, Bagnasco F, Corti P, Messina C, Fagioli F, Podda M, Prete A, Caselli D, Lanino E, Dini G, Rondelli R, Haupt R, AIEOP-HSCT Group.
    Biol Blood Marrow Transplant; 2009 Oct 01; 15(10):1271-6. PubMed ID: 19747635
    [Abstract] [Full Text] [Related]

  • 47. [Cataract in children after autologous bone marrow transplantation. A common, but curable complication].
    Frisk P, Hagberg H, Mandahl A, Söderberg P, Lönnerholm G.
    Lakartidningen; 2002 Mar 27; 99(13):1444-7. PubMed ID: 11989353
    [Abstract] [Full Text] [Related]

  • 48. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socié G.
    J Clin Oncol; 2007 Jun 10; 25(17):2449-54. PubMed ID: 17557958
    [Abstract] [Full Text] [Related]

  • 49. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood.
    Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM.
    Clin Endocrinol (Oxf); 2007 Oct 10; 67(4):589-97. PubMed ID: 17590170
    [Abstract] [Full Text] [Related]

  • 50. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A, Crawley C, Arat M, Sica S, Lutz P, Socié G, EBMT Late Effects Working Party.
    Haematologica; 2008 Aug 10; 93(8):1203-10. PubMed ID: 18556401
    [Abstract] [Full Text] [Related]

  • 51. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K.
    Biol Blood Marrow Transplant; 2008 Jan 10; 14(1):43-9. PubMed ID: 18158960
    [Abstract] [Full Text] [Related]

  • 52. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F, Lang PJ, Ottinger H, Faul C, Bethge W, Handgretinger R, Bamberg M, Belka C.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):523-8. PubMed ID: 17869449
    [Abstract] [Full Text] [Related]

  • 53. Total body irradiation-induced osteochondromata.
    Harper GD, Dicks-Mireaux C, Leiper AD.
    J Pediatr Orthop; 1998 Feb 01; 18(3):356-8. PubMed ID: 9600563
    [Abstract] [Full Text] [Related]

  • 54. Pulmonary function after autologous bone marrow transplantation in children: a long-term prospective study.
    Frisk P, Arvidson J, Bratteby LE, Hedenström H, Lönnerholm G.
    Bone Marrow Transplant; 2004 Mar 01; 33(6):645-50. PubMed ID: 14688819
    [Abstract] [Full Text] [Related]

  • 55. Renal dysfunction after total body irradiation: dose-effect relationship.
    Kal HB, van Kempen-Harteveld ML.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1228-32. PubMed ID: 16682132
    [Abstract] [Full Text] [Related]

  • 56. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P, Piñana JL, Valcárcel D, Querol L, Martino R, Sureda A, Briones J, Delgado J, Brunet S, Sierra J.
    Biol Blood Marrow Transplant; 2009 Nov 15; 15(11):1439-46. PubMed ID: 19822304
    [Abstract] [Full Text] [Related]

  • 57. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 58. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience.
    Farzin A, Davies SM, Smith FO, Filipovich A, Hansen M, Auerbach AD, Harris RE.
    Br J Haematol; 2007 Feb 15; 136(4):633-40. PubMed ID: 17367413
    [Abstract] [Full Text] [Related]

  • 59. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 15; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 60. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study.
    Ness KK, Bhatia S, Baker KS, Francisco L, Carter A, Forman SJ, Robison LL, Rosenthal J, Gurney JG.
    Arch Pediatr Adolesc Med; 2005 Aug 15; 159(8):706-13. PubMed ID: 16061776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.